EU Accelerated Assessment Tracker
Calliditas "Very Excited" By Success; Speedy Review Begins Of Takeda's Dengue Vaccine Candidate
Calliditas Therapeutics' lead product candidate Nefecon will be fast-tracked at the EMA once the marketing application is filed. Takeda and Bayer are hoping for the same success with maribavir and copanlisib respectively.